Does BENRALIZUMAB Cause Eosinophil count increased? 204 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 204 reports of Eosinophil count increased have been filed in association with BENRALIZUMAB (FASENRA). This represents 1.3% of all adverse event reports for BENRALIZUMAB.
204
Reports of Eosinophil count increased with BENRALIZUMAB
1.3%
of all BENRALIZUMAB reports
4
Deaths
43
Hospitalizations
How Dangerous Is Eosinophil count increased From BENRALIZUMAB?
Of the 204 reports, 4 (2.0%) resulted in death, 43 (21.1%) required hospitalization, and 2 (1.0%) were considered life-threatening.
Is Eosinophil count increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BENRALIZUMAB. However, 204 reports have been filed with the FAERS database.
What Other Side Effects Does BENRALIZUMAB Cause?
Asthma (2,457)
Dyspnoea (1,604)
Death (1,336)
Drug ineffective (1,266)
Cough (793)
Headache (788)
Product dose omission issue (713)
Pneumonia (710)
Wheezing (619)
Malaise (514)
What Other Drugs Cause Eosinophil count increased?
ALBUTEROL (1,359)
PREDNISONE (846)
BUDESONIDE\FORMOTEROL (719)
DUPILUMAB (712)
TIOTROPIUM (682)
MEPOLIZUMAB (670)
MONTELUKAST (504)
BUDESONIDE (493)
CLOZAPINE (475)
FLUTICASONE\SALMETEROL (416)
Which BENRALIZUMAB Alternatives Have Lower Eosinophil count increased Risk?
BENRALIZUMAB vs BENSERAZIDE
BENRALIZUMAB vs BENSERAZIDE\LEVODOPA
BENRALIZUMAB vs BENZALKONIUM
BENRALIZUMAB vs BENZOCAINE
BENRALIZUMAB vs BENZODIAZEPINE